Development of innovative antimicrobials against pathogens resistant to antimicrobials
EU — Italia · scadenza 13/04/2027
Development of innovative antimicrobials against pathogens resistant to antimicrobials
Scadenza: 13/04/2027
Fonte: eu_funding_tenders
Tipo: EU
Pagina ufficiale: Apri la scheda sulla fonte ufficiale
Scheda (fonte ufficiale)
Topic metadata
- EU Programme: Horizon Europe (ID 43108390)
- Call identifier: HORIZON-HLTH-2027-01
- Call name: Cluster 1 - Health (Single stage - 2027/1)
- Type: Topic
- Opening date: 10/02/2027
- Next deadline: 13/04/2027
- Keywords: HORIZON-HLTH-2027-01-DISEASE-08, HORIZON-HLTH-2027-01, Antibiotics, Antimicrobial resistance, Antimicrobials, Clinical development, Phase I, Clinical trials, Disease control
Topic description
Expected Outcome:
This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes:
- The scientific and clinical communities have a better understanding of and access to new and innovative products
Iscriviti o accedi per leggere e ricevere aggiornamenti sui finanziamenti.
Iscriviti oraHai già un account? Accedi